Profile data is unavailable for this security.
About the company
Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. Its principal activity is the development, sale and distribution of licensed veterinary pharmaceuticals to the Companion Animal, Production Animal and Equine veterinary markets. Its segments include Animalcare Europe and Randlab. Animalcare Europe segment is engaged in the development and marketing of pharmaceutical products that provide benefits to animal health across Europe and through the European International Partners network. Randlab segment is engaged in the development, manufacture, and distribution of veterinary pharmaceuticals and nutritional supplements tailored to the equine market. It also provides professional support services to equine veterinarians across Australia, New Zealand, the Middle East, and selected international markets. Its novel products include Plaqtiv+ and Daxocox. Daxocox is a long-acting stand for the treatment of osteoarthritic pain.
- Revenue in GBP (TTM)81.07m
- Net income in GBP2.98m
- Incorporated1972
- Employees201.00
- LocationAnimalcare Group plcMoorside, Monks CrossYORK YO32 9LBUnited KingdomGBR
- Phone+44 190 448 7687
- Fax+44 190 448 7611
- Websitehttps://www.animalcaregroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seikagaku Corp | 171.42m | -3.61m | 187.65m | 1.08k | -- | 0.5168 | 29.45 | 1.09 | -13.84 | -13.84 | 656.96 | 1,337.18 | 0.4328 | 2.03 | 3.92 | 33,360,930.00 | -0.9099 | 3.60 | -0.9881 | 3.96 | 40.92 | 52.56 | -2.10 | 7.94 | 4.26 | -- | 0.0049 | 55.17 | 8.73 | 6.57 | -44.46 | -- | 18.48 | 2.90 |
| Qinghai Spring Medicinl Rsrcs Tech CoLTD | 30.24m | -11.80m | 188.30m | 159.00 | -- | 1.72 | -- | 6.23 | -0.1864 | -0.1864 | 0.496 | 1.75 | 0.2492 | 1.08 | 4.07 | 1,790,944.00 | -9.61 | -15.06 | -10.10 | -15.66 | 31.01 | 22.84 | -38.56 | -147.18 | 8.94 | -2.61 | 0.0045 | -- | 26.36 | 2.95 | 25.80 | -- | -1.38 | -- |
| Bliss GVS Pharma Ltd | 70.17m | 8.82m | 189.80m | 966.00 | 21.80 | -- | 15.95 | 2.70 | 10.18 | 10.18 | 80.97 | -- | -- | -- | -- | 8,986,598.00 | -- | 6.04 | -- | 7.54 | 52.65 | 46.33 | 13.18 | 9.45 | -- | 8.44 | -- | 8.27 | 5.13 | 3.27 | 11.72 | -2.82 | 5.18 | 0.00 |
| Laboratorio Reig Jofre SA | 285.11m | 3.70m | 191.61m | 1.42k | 51.43 | 1.01 | 11.32 | 0.672 | 0.0521 | 0.0521 | 4.04 | 2.67 | 0.9341 | 1.88 | 5.34 | 231,058.50 | 1.24 | 2.39 | 1.61 | 3.15 | 60.48 | 60.25 | 1.32 | 2.78 | 0.9907 | 4.94 | 0.2265 | -- | 7.22 | 11.10 | 10.36 | 16.00 | -7.77 | -- |
| Lifecore Biomedical Inc | -73.38bn | -73.38bn | 194.64m | 406.00 | -- | -- | -- | -- | -- | -- | -- | 0.9818 | -- | -- | -- | -- | -- | -7.91 | -- | -10.85 | -- | 32.86 | -- | -23.15 | 1.67 | -- | 0.787 | -- | 0.4725 | -4.24 | -575.39 | -- | -12.85 | -- |
| Animalcare Group Plc | 81.07m | 2.98m | 194.71m | 201.00 | 66.18 | 1.72 | 17.47 | 2.40 | 0.0426 | 0.0426 | 1.24 | 1.64 | 0.5644 | 2.79 | 5.78 | 403,343.30 | 2.08 | 1.33 | 2.42 | 1.58 | 56.36 | 55.54 | 3.68 | 2.23 | 1.27 | -- | 0.1566 | 176.02 | 4.94 | 0.858 | 339.11 | -- | 4.71 | 20.11 |
| Daito Pharmaceutical Co Ltd | 244.72m | 10.67m | 196.36m | 1.07k | 18.34 | 0.774 | 6.20 | 0.8024 | 74.42 | 74.42 | 1,703.91 | 1,763.62 | 0.6544 | 2.16 | 2.76 | 47,716,680.00 | 2.90 | 5.12 | 3.71 | 6.67 | 17.63 | 21.75 | 4.43 | 7.35 | 1.31 | -- | 0.1739 | 24.48 | 7.99 | 2.39 | -42.09 | -13.52 | 20.45 | 14.00 |
| Cipher Pharmaceuticals Inc | 36.72m | 12.74m | 198.88m | 61.00 | 16.35 | 2.39 | 11.16 | 5.42 | 0.8939 | 0.8939 | 2.57 | 6.12 | 0.3322 | 2.15 | 4.29 | 1,118,770.00 | 11.52 | 19.63 | 13.03 | 23.17 | 74.32 | 79.74 | 34.69 | 59.54 | 0.9766 | 5.74 | 0.1052 | 0.00 | 57.66 | 8.24 | -43.36 | 34.34 | 127.59 | -- |
| Abeona Therapeutics Inc | 293.50k | 60.43m | 199.21m | 136.00 | 4.53 | 1.53 | 3.21 | 678.75 | 1.11 | 1.11 | 0.0073 | 3.27 | 0.0023 | -- | 0.2478 | 2,941.18 | 46.83 | -62.23 | 52.94 | -78.23 | -122.00 | -- | 20,587.50 | -1,824.21 | 9.53 | -- | 0.1034 | -- | -100.00 | -- | -17.62 | -- | -17.78 | -- |
| Pyridam Farma Tbk PT | 122.91m | -21.01m | 201.04m | 2.34k | -- | 6.29 | -- | 1.64 | -76.90 | -76.90 | 326.28 | 65.22 | 0.4401 | 4.30 | 3.88 | 1,450,964,000.00 | -7.52 | -1.59 | -10.76 | -2.02 | 23.36 | 35.12 | -17.09 | -2.65 | 0.736 | -0.4821 | 0.8735 | -- | 173.59 | 50.70 | -287.52 | -- | 110.52 | -- |
| Evolus Inc | 209.73m | -42.97m | 204.52m | 329.00 | -- | -- | -- | 0.9752 | -0.9125 | -0.9125 | 4.46 | -0.4441 | 1.27 | 4.09 | 6.01 | 860,912.60 | -26.11 | -37.04 | -36.48 | -57.14 | 65.83 | 65.19 | -20.49 | -51.26 | 1.53 | -2.13 | 1.25 | -- | 31.76 | 50.12 | 18.26 | -- | 1.10 | -- |
| Spectral Medical Inc | 1.46m | -22.44m | 204.66m | 29.00 | -- | -- | -- | 140.60 | -0.1455 | -0.1456 | 0.0095 | -0.2375 | 0.331 | 4.43 | 7.03 | 93,275.86 | -510.19 | -135.57 | -- | -711.89 | 56.16 | 55.19 | -1,541.33 | -581.02 | 0.1044 | -0.1904 | -- | -- | 43.05 | -4.43 | 0.7223 | -- | -30.03 | -- |
Data as of Feb 17 2026. Currency figures normalised to Animalcare Group plc's reporting currency: UK Pound GBX
54.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harwood Capital LLPas of 02 Jan 2026 | 12.48m | 18.08% |
| Liontrust Investment Partners LLPas of 17 Nov 2025 | 6.71m | 9.72% |
| Canaccord Genuity Wealth Ltd.as of 31 Mar 2025 | 4.31m | 6.24% |
| BGF Investment Management Ltd.as of 31 Mar 2025 | 4.00m | 5.80% |
| BlackRock Investment Management (UK) Ltd.as of 05 Nov 2025 | 3.36m | 4.87% |
| Octopus Investments Ltd.as of 20 Jan 2026 | 2.81m | 4.08% |
| Unicorn Asset Management Ltd.as of 03 Nov 2025 | 1.68m | 2.44% |
| Rathbones Investment Management Ltd.as of 03 Nov 2025 | 815.00k | 1.18% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Jan 2025 | 677.58k | 0.98% |
| Royal London Asset Management Ltd.as of 03 Nov 2025 | 650.00k | 0.94% |
More ▼
Data from 30 Sep 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
